Powered by
-Sage Therapeutics to Present at J.P. Morgan Healthcare Conference on Tuesday January 9 2018

CAMBRIDGE, Mass. - Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that the Company is scheduled to present at the J.P. Morgan 2018 Healthcare Conference in San Francisco on Tuesday, January 9, 2018at 11:30 a.m. PT (2:30 p.m. ET), followed by a Q&A session.

A live webcast of the presentation and Q&A session can be accessed on the investor page of Sage's web

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox